Kymera Therapeutics
KYMR
KYMR
126 hedge funds and large institutions have $1.68B invested in Kymera Therapeutics in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+7
Holders Change %
+5.88%
% of All Funds
2.02%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
46
Reduced
41
Closed
9
Calls
$22M
Puts
$2.6M
Net Calls
+$19.4M
Net Calls Change
-$1.31M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AGP
126
Artia Global Partners
Miami,
Florida
| – | -$749K | -30,000 | Closed |
|
127
Squarepoint
New York
| – | -$546K | -21,878 | Closed |
|
|
SSA
128
Schonfeld Strategic Advisors
New York
| – | -$434K | -17,400 | Closed |
|
|
GCP
129
GSA Capital Partners
London,
United Kingdom
| – | -$332K | -13,301 | Closed |
|
130
Rockefeller Capital Management
New York
| – | -$260K | -10,423 | Closed |
|
131
Belvedere Trading
Chicago,
Illinois
| – | -$194K | -7,775 | Closed |
|
|
LC
132
Lindbrook Capital
Calabasas,
California
| – | -$300 | -12 | Closed |
|